"Master the art of value beyond the pill to secure commercial success" - eyeforpharma

In an industry where it’s increasingly difficult to gain entry in the first place – providing added value for your patients and core customers is essential to secure and maintain market share.

To help you deliver genuine added value, eyeforpharma collaborated with industry thought leaders from Boehringer Ingelheim, Bayer, Lundbeck and Janssen Diagnostics and more on the recently released Value Added Service (VAS) Report extract.

Click here to read the VAS report extract: http://goo.gl/gyWDR8

Enjoy!